Blueshift Asset Management’s Gilead Sciences GILD Stock Holding History

Blueshift Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Buy	+3,643	New	+$480K	0.11%	240
2024 Q2	–	Sell	-4,446	Closed	-$326K	–	365
2024 Q1	$326K	Buy	+4,446	New	+$342K	0.17%	189
2023 Q3	–	Sell	-5,001	Closed	-$385K	–	329
2023 Q2	$385K	Buy	5,001 +2,130	+74%	+$170K	0.15%	171
2023 Q1	$238K	Buy	+2,871	New	+$238K	0.1%	269
2022 Q2	–	Sell	-46,496	Closed	-$2.76M	–	798
2022 Q1	$2.76M	Buy	46,496 +37,078	+394%	+$2.37M	0.25%	107
2021 Q4	$684K	Buy	9,418 +5,852	+164%	+$403K	0.06%	383
2021 Q3	$249K	Buy	+3,566	New	+$251K	0.01%	878
2021 Q2	–	Sell	-8,605	Closed	-$556K	–	1003
2021 Q1	$556K	Buy	+8,605	New	+$555K	0.06%	437
2019 Q4	–	Sell	-10,254	Closed	-$650K	–	871
2019 Q3	$650K	Buy	10,254 +6,666	+186%	+$436K	0.1%	296
2019 Q2	$242K	Buy	+3,588	New	+$236K	0.03%	612

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blueshift Asset Management's GILD Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,643 shares worth $460K. The stake represents 0.11% of the portfolio and ranks #240 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in GILD as recently as Q1 2024.

Blueshift Asset Management first reported a position in GILD in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.76M in Q1 2022. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Blueshift Asset Management held 3,643 shares of Gilead Sciences worth $460K as of Q2 2026.
Gilead Sciences was a new Blueshift Asset Management position in Q2 2026.
Gilead Sciences made up 0.11% of Blueshift Asset Management's portfolio in Q2 2026, its #240 holding.
Blueshift Asset Management first reported a position in Gilead Sciences in Q2 2019 and has held it in 10 quarters since.
Blueshift Asset Management's Gilead Sciences position peaked at $2.76M in Q1 2022.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.